Advanced Search
Development of Clarithromycin Sustained-Release Tablets[J]. Journal of China Pharmaceutical University, 2003, (2): 36-40.
Citation: Development of Clarithromycin Sustained-Release Tablets[J]. Journal of China Pharmaceutical University, 2003, (2): 36-40.

Development of Clarithromycin Sustained-Release Tablets

  • The purpose is to develop a sustained releas e dosage form of charithromycin(CLM) as hydrogel matrix tablet for using only once daily and evaluate its in vitro re lease characteristics. The formulations were screened acc ording to the re lease prof
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return